Strengthening and transforming the pharmaceutical supply chain
European Pharmaceutical Review
JULY 21, 2023
Recommendations were also published earlier this year for all stakeholders in the pharma supply chain. In this Q&A EPR speaks to Naser Al Yammahi the Deputy CEO of Hayat Biotech about pharmaceutical supply chain challenges and how they can be addressed. What types of medicinal products are in short supply and why?
Let's personalize your content